Price (delayed)
$1.24
Market cap
$14.5M
P/E Ratio
10.33
Dividend/share
N/A
EPS
$0.12
Enterprise value
-$2.82M
Synlogic™ is bringing the transformative potential of synthetic biology to medicine. With a premiere synthetic biology platform that leverages a reproducible, modular approach to microbial engineering, Synlogic designs Synthetic Biotic
There are no recent dividends present for SYBX.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.